← Leaderboards
Narayan R Bhat
Medical University Of South Carolina
$5,057,283
Attributed
$5,262,845
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $508.2K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,262,845 · 9
By mechanism
R01$3,015,431 · 3
R21$2,050,012 · 5
P01$197,402 · 1
Top collaborators
- Andy Y Shih2 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Besim Ogretmen$19,638,711
- Daohong Zhou$16,846,361
- Natalia Ivanovna Krupenko$2,526,008
- Naren L Banik$13,192,318
- Gavin Yong Wang$2,707,147
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMediatingPlayBrainMicrogliaS DiseaseNeuronsBiochemicalAmyloidGeneticLinkPathogenesisIn VivoMitogen Activated Protein KinaseDementiaInjuryBlood VesselsLaboratory RatOligodendrogliaNitric Oxide SynthaseImmunocytochemistryNeurotoxicResponseTransgenic Mice
Grant awards (24)
Ceramide Signaling in AD Pathogenesis$411,125
R21 · FY2020 · AG · contact PI
Redox-based Targeting of Cerebrovascular Dysfunction in AD$186,875
R21 · FY2019 · AG · contact PI
Redox-based Targeting of Cerebrovascular Dysfunction in AD$224,250
R21 · FY2018 · AG · contact PI
Pericytes as Inducers of Blood-brain Barrier Injury During Stroke$186,875
R21 · FY2017 · NS
Targeting Neurovascular Dysfunction in AD$186,875
R21 · FY2017 · AG · contact PI
Targeting Neurovascular Dysfunction in AD$224,250
R21 · FY2016 · AG · contact PI
Pericytes as Inducers of Blood-brain Barrier Injury During Stroke$224,250
R21 · FY2016 · NS
Atherogenic Induction of Neuroinflammation$184,356
R21 · FY2010 · NS · contact PI
Neuroinflammation in Cholesterol-Induced AD Pathogenesis$287,077
R01 · FY2009 · NS · contact PI
Atherogenic Induction of Neuroinflammation$221,156
R21 · FY2009 · NS · contact PI
Neuroinflammation in Cholesterol-Induced AD Pathogenesis$287,077
R01 · FY2008 · NS · contact PI
Neuroinflammation in Cholesterol-Induced AD Pathogenesis$287,077
R01 · FY2007 · NS · contact PI
NEUROINFLAMMATION AND THE AGED DOPINERGIC SYSTEM$117,436
P01 · FY2007 · AG · contact PI
Neuroinflammation in Cholesterol-Induced AD Pathogenesis$285,300
R01 · FY2006 · NS · contact PI
NEUROINFLAMMATION AND THE AGED DOPINERGIC SYSTEM$79,966
P01 · FY2006 · AG · contact PI
MAP KINASES IN OLIGODENDROCYTE CELL SIGNALING$242,725
R01 · FY2005 · NS
MAP KINASES IN OLIGODENDROCYTE CELL SIGNALING$242,725
R01 · FY2004 · NS
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION$214,500
R01 · FY2004 · NS
MAP KINASES IN OLIGODENDROCYTE CELL SIGNALING$242,725
R01 · FY2003 · NS
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION$214,500
R01 · FY2003 · NS
MAP KINASES IN OLIGODENDROCYTE CELL SIGNALING$242,725
R01 · FY2002 · NS
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION$214,500
R01 · FY2002 · NS
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION$15,000
R01 · FY2002 · NS
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION$239,500
R01 · FY2001 · NS